These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10730506)

  • 1. Treatment options for Alzheimer's disease.
    Dinsmore ST
    J Am Osteopath Assoc; 1999 Sep; 99(9 Suppl):S6-8. PubMed ID: 10730506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-cholinergic strategies for treating and preventing Alzheimer's disease.
    Doraiswamy PM
    CNS Drugs; 2002; 16(12):811-24. PubMed ID: 12421115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current pharmacotherapies for Alzheimer's disease.
    Knopman DS
    Geriatrics; 1998 Sep; 53 Suppl 1():S31-4. PubMed ID: 9745634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic approaches to cognitive deficits in Alzheimer's disease.
    Peskind ER
    J Clin Psychiatry; 1998; 59 Suppl 9():22-7. PubMed ID: 9720483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study.
    Mazza M; Capuano A; Bria P; Mazza S
    Eur J Neurol; 2006 Sep; 13(9):981-5. PubMed ID: 16930364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacological effects of ginkgo biloba, a plant extract, on the brain of dementia patients in comparison with tacrine.
    Itil TM; Eralp E; Ahmed I; Kunitz A; Itil KZ
    Psychopharmacol Bull; 1998; 34(3):391-7. PubMed ID: 9803773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy for early Alzheimer's disease: what are we waiting for?
    Doraiswamy PM; Steffens DC
    J Am Geriatr Soc; 1998 Oct; 46(10):1322-4. PubMed ID: 9777922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicinal plants and Alzheimer's disease: from ethnobotany to phytotherapy.
    Perry EK; Pickering AT; Wang WW; Houghton PJ; Perry NS
    J Pharm Pharmacol; 1999 May; 51(5):527-34. PubMed ID: 10411211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manipulation of the cholinergic system.
    Geroldi C; Bianchetti A; Trabucchi M
    Funct Neurol; 1997; 12(3-4):187-91. PubMed ID: 9218975
    [No Abstract]   [Full Text] [Related]  

  • 10. Cholinesterase inhibitors and Gingko extracts--are they comparable in the treatment of dementia? Comparison of published placebo-controlled efficacy studies of at least six months' duration.
    Wettstein A
    Phytomedicine; 2000 Jan; 6(6):393-401. PubMed ID: 10755847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What's new in Alzheimer's disease treatment? Reasons for optimism about future pharmacologic options.
    Shadlen MF; Larson EB
    Postgrad Med; 1999 Jan; 105(1):109-18. PubMed ID: 9924498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.
    Wilkinson DG; Francis PT; Schwam E; Payne-Parrish J
    Drugs Aging; 2004; 21(7):453-78. PubMed ID: 15132713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacology.
    Nordberg A; Svensson AL
    Drug Saf; 1998 Dec; 19(6):465-80. PubMed ID: 9880090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phytochemical and medicinal importance of Ginkgo biloba L.
    Mohanta TK; Tamboli Y; Zubaidha PK
    Nat Prod Res; 2014; 28(10):746-52. PubMed ID: 24499319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives in clinical Alzheimer's disease research and the development of antidementia drugs.
    Grundman M; Corey-Bloom J; Thal LJ
    J Neural Transm Suppl; 1998; 53():255-75. PubMed ID: 9700663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative drug therapies for dementia.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2011 May; 49(5):17-20. PubMed ID: 21553703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive enhancement therapy for Alzheimer's disease. The way forward.
    Parnetti L; Senin U; Mecocci P
    Drugs; 1997 May; 53(5):752-68. PubMed ID: 9129864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practice guidelines for the diagnosis and treatment of Alzheimer's disease in a managed care setting: Part II--Pharmacologic therapy. Alzheimer's Disease (AD) Managed Care Advisory Council.
    Fillit H; Cummings J
    Manag Care Interface; 2000 Jan; 13(1):51-6. PubMed ID: 10747691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future therapeutic approaches to Alzheimer's disease.
    Davis KL
    J Clin Psychiatry; 1998; 59 Suppl 11():14-6. PubMed ID: 9731545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medications for the treatment of Alzheimer's disease.
    Lampley-Dallas VT
    J Okla State Med Assoc; 2001 Aug; 94(8):347-9. PubMed ID: 11515383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.